ACRS logo

Aclaris Therapeutics (ACRS) Free Cash Flow

Annual FCF

-$79.63 M
-$11.46 M-16.81%

December 31, 2023


Summary


Performance

ACRS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRScash flowmetrics:

Quarterly FCF

$22.00 M
+$34.31 M+278.75%

September 30, 2024


Summary


Performance

ACRS Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRScash flowmetrics:

TTM FCF

-$18.46 M
+$46.64 M+71.64%

September 30, 2024


Summary


Performance

ACRS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRScash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ACRS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.8%+189.3%+79.9%
3 y3 years-103.7%+306.3%+58.1%
5 y5 years+22.1%+191.0%+74.8%

ACRS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-51.9%at lowat high+181.8%at high+79.9%
5 y5-year-103.7%+18.8%at high+181.8%at high+81.2%
alltimeall time-1518.6%+22.1%at high+169.6%-541.2%+83.5%

Aclaris Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
$22.00 M(-278.7%)
-$18.46 M(-71.6%)
Jun 2024
-
-$12.31 M(-41.3%)
-$65.10 M(-11.6%)
Mar 2024
-
-$20.95 M(+190.9%)
-$73.68 M(-7.5%)
Dec 2023
-$79.63 M(+16.8%)
-$7.20 M(-70.8%)
-$79.63 M(-13.1%)
Sep 2023
-
-$24.64 M(+18.0%)
-$91.65 M(+22.2%)
Jun 2023
-
-$20.89 M(-22.4%)
-$74.98 M(+1.4%)
Mar 2023
-
-$26.91 M(+40.0%)
-$73.94 M(+8.5%)
Dec 2022
-$68.17 M(+30.0%)
-$19.22 M(+141.2%)
-$68.17 M(+2.9%)
Sep 2022
-
-$7.97 M(-59.9%)
-$66.23 M(-3.9%)
Jun 2022
-
-$19.85 M(-6.1%)
-$68.92 M(+12.4%)
Mar 2022
-
-$21.13 M(+22.3%)
-$61.34 M(+17.0%)
Dec 2021
-$52.44 M(+34.2%)
-$17.27 M(+62.0%)
-$52.44 M(+19.1%)
Sep 2021
-
-$10.66 M(-13.1%)
-$44.03 M(-3.9%)
Jun 2021
-
-$12.27 M(+0.3%)
-$45.82 M(+3.2%)
Mar 2021
-
-$12.23 M(+38.0%)
-$44.39 M(+13.6%)
Dec 2020
-$39.09 M(-60.1%)
-$8.87 M(-28.8%)
-$39.09 M(-23.2%)
Sep 2020
-
-$12.45 M(+14.9%)
-$50.88 M(-18.7%)
Jun 2020
-
-$10.84 M(+56.4%)
-$62.60 M(-14.7%)
Mar 2020
-
-$6.93 M(-66.5%)
-$73.39 M(-25.2%)
Dec 2019
-$98.06 M
-$20.66 M(-14.6%)
-$98.06 M(-6.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$24.18 M(+11.9%)
-$104.80 M(-5.6%)
Jun 2019
-
-$21.62 M(-31.6%)
-$111.03 M(-0.5%)
Mar 2019
-
-$31.60 M(+15.4%)
-$111.60 M(+9.2%)
Dec 2018
-$102.17 M(+82.8%)
-$27.39 M(-9.9%)
-$102.17 M(+9.2%)
Sep 2018
-
-$30.42 M(+37.1%)
-$93.56 M(+21.3%)
Jun 2018
-
-$22.18 M(+0.1%)
-$77.13 M(+18.3%)
Mar 2018
-
-$22.17 M(+18.0%)
-$65.21 M(+16.7%)
Dec 2017
-$55.90 M(+60.5%)
-$18.79 M(+34.3%)
-$55.90 M(+23.5%)
Sep 2017
-
-$13.98 M(+36.1%)
-$45.24 M(+9.7%)
Jun 2017
-
-$10.27 M(-20.1%)
-$41.23 M(+1.2%)
Mar 2017
-
-$12.85 M(+58.0%)
-$40.76 M(+17.0%)
Dec 2016
-$34.84 M(+66.9%)
-$8.13 M(-18.4%)
-$34.84 M(+12.5%)
Sep 2016
-
-$9.97 M(+1.7%)
-$30.97 M(-2.3%)
Jun 2016
-
-$9.80 M(+41.3%)
-$31.70 M(+27.2%)
Mar 2016
-
-$6.93 M(+62.4%)
-$24.93 M(+19.4%)
Dec 2015
-$20.88 M(+159.2%)
-$4.27 M(-60.1%)
-$20.88 M(+25.7%)
Sep 2015
-
-$10.70 M(+253.5%)
-$16.61 M(+181.2%)
Jun 2015
-
-$3.03 M(+5.1%)
-$5.91 M(+105.1%)
Mar 2015
-
-$2.88 M
-$2.88 M
Dec 2014
-$8.05 M(+63.7%)
-
-
Dec 2013
-$4.92 M
-
-

FAQ

  • What is Aclaris Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Aclaris Therapeutics?
  • What is Aclaris Therapeutics annual FCF year-on-year change?
  • What is Aclaris Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Aclaris Therapeutics?
  • What is Aclaris Therapeutics quarterly FCF year-on-year change?
  • What is Aclaris Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Aclaris Therapeutics?
  • What is Aclaris Therapeutics TTM FCF year-on-year change?

What is Aclaris Therapeutics annual free cash flow?

The current annual FCF of ACRS is -$79.63 M

What is the all time high annual FCF for Aclaris Therapeutics?

Aclaris Therapeutics all-time high annual free cash flow is -$4.92 M

What is Aclaris Therapeutics annual FCF year-on-year change?

Over the past year, ACRS annual free cash flow has changed by -$11.46 M (-16.81%)

What is Aclaris Therapeutics quarterly free cash flow?

The current quarterly FCF of ACRS is $22.00 M

What is the all time high quarterly FCF for Aclaris Therapeutics?

Aclaris Therapeutics all-time high quarterly free cash flow is $22.00 M

What is Aclaris Therapeutics quarterly FCF year-on-year change?

Over the past year, ACRS quarterly free cash flow has changed by +$46.64 M (+189.28%)

What is Aclaris Therapeutics TTM free cash flow?

The current TTM FCF of ACRS is -$18.46 M

What is the all time high TTM FCF for Aclaris Therapeutics?

Aclaris Therapeutics all-time high TTM free cash flow is -$2.88 M

What is Aclaris Therapeutics TTM FCF year-on-year change?

Over the past year, ACRS TTM free cash flow has changed by +$73.19 M (+79.86%)